Skip to main content
logo
Bliss GVS Pharma Limited (NSE:BLISSGVS)
India flag India · Delayed Price · Currency is INR
650.05
-4.70 (-0.72%)
Nov 11, 2026, 1:50 PM IST

Bliss GVS Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,6121,291842.99754.54708.59150.4
Depreciation & Amortization
373.85334.14293.21262.57185.13171.33
Other Amortization
0.690.690.971.231.611.98
Loss (Gain) From Sale of Assets
-0.7221.094.92-2.86-3.65-1.38
Asset Writedown & Restructuring Costs
8.25.42----
Loss (Gain) From Sale of Investments
14.64339.1225.75---
Stock-Based Compensation
124.7286.2441.438.1639.0457.08
Provision & Write-off of Bad Debts
258.13242.72214.88252.74228.07227.8
Other Operating Activities
403.98110.91149.58187.535.5413.87
Change in Accounts Receivable
-1,124-883.65-415.89-445.19-149.98512.91
Change in Inventory
-804.42-455-304.54-224.22150.03-290.97
Change in Accounts Payable
180.65326.16108.38-251-63.16183.44
Change in Other Net Operating Assets
-78.91-31.9697.49454.7-788.08328.34
Operating Cash Flow
968.61,3871,0591,028343.141,355
Operating Cash Flow Growth
-28.72%30.97%3.01%199.64%-74.67%111.79%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-592.86-568.31-762.86-283.29-937.99-740.03
Sale of Property, Plant & Equipment
-68.525.3534.126.036.9110.68
Cash Acquisitions
--2.23----
Divestitures
085.14----
Investment in Securities
129.9-93.19-191.7539.54-54.58-22.31
Other Investing Activities
270.78170.45164.56-1,094908.15-178.09
Investing Cash Flow
-260.69-382.8-755.87-831.9-77.51-929.75

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-42.53552.73154.88400.22107.56
Long-Term Debt Repaid
--693.9-762.34-272.36-552.68-284.81
Lease Payments
-69.7-50.24-44.88-28.52-13.73-21.2
Net Debt Issued (Repaid)
-365.35-651.37-209.61-117.48-152.46-177.26
Issuance of Common Stock
29.761828.8623.520.4222.84
Common Dividends Paid
-159.22-106.37-53.95-53.95-54.37-53.27
Other Financing Activities
-137.26-152.38-67.29-61-62.97-29.62
Financing Cash Flow
-632.06-892.11-301.98-208.93-249.39-237.3

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.820.970.99-1.513.96-99.23
Net Cash Flow
76.67113.252.26-14.1630.288.53

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
375.73818.87296.27744.87-594.86614.78
Free Cash Flow Growth
-41.96%176.39%-60.23%--12.09%
Free Cash Flow Margin
3.50%8.83%3.66%9.67%-7.92%8.22%
Free Cash Flow Per Share
3.477.612.797.02-5.645.84
Levered Free Cash Flow
458.97949.59155.0319.06-184.611,059
Unlevered Free Cash Flow
505.031,025205.7856.88-122.961,082
Free Cash Flow After Leases
306.04768.62251.39716.36-608.58593.58

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
135.37149.3468.216162.9729.62
Cash Income Tax Paid
572.19416.52366.36348.51445.55339.43
Change in Working Capital
-1,827-1,044-514.56-465.71-851.19733.73